Levi Angelique W, Kelly Deidre P, Rosenthal Dorothy L, Ronnett Brigitte M
Division of Cytopathology, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Cancer. 2003 Aug 25;99(4):191-7. doi: 10.1002/cncr.11507.
Human papillomavirus (HPV) DNA testing for high-risk types after Papanicolaou (Pap) smear interpretations of atypical squamous cells of undetermined significance (ASCUS) is a sensitive method for identifying women who harbor underlying high-grade squamous intraepithelial lesions (HSIL). To the authors' knowledge, the application of HPV testing to ASCUS smears in routine practice with comparison of probabilistic and interpretive models of cytologic reporting has not been reported.
HPV DNA testing was performed reflexively on 216 liquid-based Pap smears that initially were interpreted as ASCUS. According to the interpretive model, ASCUS interpretations were modified and reported as either low-grade squamous intraepithelial lesions (LSIL) or squamous intraepithelial lesions (SIL) when HPV positive and as reactive when HPV negative. Using the probabilistic model, ASCUS interpretations were maintained and simply reported with the HPV test result. Histologic follow-up data were obtained.
Of the 216 women with ASCUS cytology, 142 (65.7%) were positive for high-risk HPV types. Of the 142 HPV-positive ASCUS smears, 101 (71.1%) were modified to an interpretation of LSIL (96 cases) or SIL (5 cases). Histologic follow-up of 55 of the 101 HPV-positive smears in the interpretive group and 26 of the 41 HPV-positive smears in the probabilistic group yielded similar percentages of lesions (18 lesions [32.7%] and 9 lesions [34.6%], respectively). However, there was a preponderance of low-grade lesions in the interpretive group (89%) but a nearly equal distribution of low-grade and high-grade lesions in the probabilistic group (56% and 44%, respectively); overall, 22% of the lesions were high-grade. Of the 74 HPV-negative ASCUS smears, 71 (96%) were modified to reactive and all 5 with histologic follow-up were judged as negative.
Colposcopy with tissue studies was virtually restricted to HPV-positive cases, regardless of the reporting model used, suggesting that clinicians are basing colposcopy triage on the HPV test result rather than the definitiveness of the cytologic interpretation. This observation, the similar yield of lesions in both groups, and the significant risk of high-grade lesions argue against application of the interpretive model to HPV-tested ASCUS cases.
在巴氏涂片检查结果为意义不明确的非典型鳞状细胞(ASCUS)后进行高危型人乳头瘤病毒(HPV)DNA检测,是一种识别潜在高级别鳞状上皮内病变(HSIL)女性的敏感方法。据作者所知,在常规实践中对ASCUS涂片应用HPV检测并比较细胞学报告的概率模型和解释模型的情况尚未见报道。
对216例最初诊断为ASCUS的液基巴氏涂片进行HPV DNA检测。根据解释模型,当HPV阳性时,将ASCUS诊断修正并报告为低级别鳞状上皮内病变(LSIL)或鳞状上皮内病变(SIL),当HPV阴性时报告为反应性改变。使用概率模型时,维持ASCUS诊断并简单报告HPV检测结果。获取组织学随访数据。
在216例ASCUS细胞学检查的女性中,142例(65.7%)高危型HPV检测呈阳性。在142例HPV阳性的ASCUS涂片中,101例(71.1%)诊断修正为LSIL(96例)或SIL(5例)。对解释组101例HPV阳性涂片中的55例和概率组41例HPV阳性涂片中的26例进行组织学随访,病变比例相似(分别为18例[32.7%]和9例[34.6%])。然而,解释组中低级别病变占优势(89%),而概率组中低级别和高级别病变分布几乎相等(分别为56%和44%);总体而言,22%的病变为高级别。在74例HPV阴性的ASCUS涂片中,71例(96%)诊断修正为反应性改变,所有5例有组织学随访的均判定为阴性。
无论使用何种报告模型,组织学检查的阴道镜检查实际上都局限于HPV阳性病例,这表明临床医生进行阴道镜检查分诊是基于HPV检测结果而非细胞学解释的确定性。这一观察结果、两组病变检出率相似以及高级别病变的显著风险,均表明不应对经HPV检测的ASCUS病例应用解释模型。